Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0M0 Prostate Cancer

NCT00951535 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT00951535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00951535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0M0 Prostate Cancer
Lead sponsor
Cancer Trials Ireland
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 20, 2009
Completion date
June 30, 2026
Enrollment
251 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer